JCR Pharmaceuticals holds

Related by string. * JCRs : JCR JSR . JCR Licklider . ISI JCR #-# . JCR VIS . JCR compliant / pharmaceuticals . PHARMACEUTICALS . PHARMACEUTICAL . pharmaceutical : Barr Pharmaceuticals Inc. . Pharmaceutical Benefits Scheme . MAP Pharmaceuticals generates . Active Pharmaceutical Ingredients / holding . Holder . Holds . HOLDING : Eric Holder . Roche Holding AG . AK Steel Holding . holds BS * *

Related by context. Frequent words. (Click for all words.) 51 Benchmark indexes rose 51 sublicensed 50 Epson disclaims 49 intravenous formulations 49 UltiMAb R 49 Kyowa Hakko Kirin 47 Dynepo 46 Commercialization Agreement 45 Bayer Schering 45 Plenaxis R 44 Meda AB 44 GVAX R 44 Orphan Drug designation 43 Marketing Authorisation 43 sublicenses 43 issuable pursuant 43 Rotarix R 43 amrubicin 43 FDA Orphan Drug 43 Product Characteristics 43 shares issuable upon 43 Marketing Authorization 42 rights 42 lubiprostone 42 ROTATEQ 42 Orphan Drug status 41 OPANA ER 41 Enablex 41 OF OPERATIONS unaudited 41 Actimmune R 41 amounts Quarter Ended 41 StHelenaStar.com 41 nonexclusive 41 submitted Marketing Authorization 41 Aloxi R 41 Legal Ramifications 41 orphan designation 41 Orphan Medicinal Product 41 PROFILE COUNTRY 40 www.crucell.com 40 pediatric exclusivity 40 Paraplatin 40 Operations Amounts 40 ATK undertakes 40 except 40 PROVIGIL 40 Arigene 40 Application MAA 40 STATEMENTS OF OPERATIONS unaudited 39 methylnaltrexone 39 STATEMENTS OF INCOME Unaudited 39 Per Share Amounts Unaudited 39 palonosetron 39 exclusivities 39 Recothrom 39 Icatibant 39 Licensing Agreement 39 Lead Plaintiff status 39 NV Organon 38 Transition Therapeutics 38 orphan medicinal product 38 OF INCOME Unaudited 38 AND COMPREHENSIVE INCOME 38 OPERATIONS Dollars 38 Novartis 38 granted Orphan Drug 38 Subsequent Offering 38 TRIPS Agreement 38 Third Quarter Nine Months 38 pafuramidine 38 NASDAQ CRXL 38 issuable upon exercise 38 Camptosar 38 amlodipine besylate 38 Movetis 38 ATryn ® 38 Ended Three Months 38 IMVAMUNE R 38 unaudited Nine Months 37 VANTAS 37 unaudited Six Months 37 AND DECEMBER 37 Fortical 37 nonexclusive license 37 Sensipar 37 GAAP FINANCIAL MEASURES 37 Teva Pharma 37 Please respond insightfully 37 Data Unaudited Dollars 37 exclusive distributorship 37 UNAUDITED Three Months 37 CEFF 37 Unaudited Six Months 37 FINANCIAL MEASURES 37 Crucell NV Euronext 37 Periostat 37 faropenem 37 SANCTURA XR 37 Nine Months Ended Nine 37 sublicensing 37 AMRIX

Back to home page